Stephens Inc’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,094
| Closed | -$80K | – | 1319 |
|
|
2024
Q1 | $80K | Hold |
1,094
| – | – | ﹤0.01% | 1260 |
|
|
2023
Q4 | $78.1K | Sell |
1,094
-54
| -5% | -$3.86K | ﹤0.01% | 1168 |
|
|
2023
Q3 | $68.8K | Sell |
1,148
-600
| -34% | -$36K | ﹤0.01% | 1127 |
|
|
2023
Q2 | $126K | Sell |
1,748
-40
| -2% | -$2.88K | ﹤0.01% | 1114 |
|
|
2023
Q1 | $132K | Buy |
1,788
+5
| +0.3% | +$368 | ﹤0.01% | 1076 |
|
|
2022
Q4 | $119K | Sell |
1,783
-1,075
| -38% | -$71.8K | ﹤0.01% | 1061 |
|
|
2022
Q3 | $154K | Sell |
2,858
-77
| -3% | -$4.15K | ﹤0.01% | 1053 |
|
|
2022
Q2 | $163K | Sell |
2,935
-88
| -3% | -$4.89K | ﹤0.01% | 1087 |
|
|
2022
Q1 | $212K | Sell |
3,023
-375
| -11% | -$26.3K | ﹤0.01% | 1158 |
|
|
2021
Q4 | $327K | Buy |
3,398
+128
| +4% | +$12.3K | ﹤0.01% | 1014 |
|
|
2021
Q3 | $284K | Buy |
3,270
+152
| +5% | +$13.2K | ﹤0.01% | 1069 |
|
|
2021
Q2 | $255K | Buy |
3,118
+63
| +2% | +$5.15K | ﹤0.01% | 1103 |
|
|
2021
Q1 | $291K | Sell |
3,055
-2,740
| -47% | -$261K | ﹤0.01% | 1014 |
|
|
2020
Q4 | $360K | Buy |
5,795
+338
| +6% | +$21K | 0.01% | 866 |
|
|
2020
Q3 | $324K | Buy |
5,457
+156
| +3% | +$9.26K | 0.01% | 849 |
|
|
2020
Q2 | $370K | Sell |
5,301
-34,841
| -87% | -$2.43M | 0.01% | 781 |
|
|
2020
Q1 | $1.82M | Sell |
40,142
-1,637
| -4% | -$74.3K | 0.05% | 362 |
|
|
2019
Q4 | $2.72M | Sell |
41,779
-2,196
| -5% | -$143K | 0.06% | 336 |
|
|
2019
Q3 | $2.73M | Sell |
43,975
-2,119
| -5% | -$132K | 0.06% | 331 |
|
|
2019
Q2 | $3.28M | Sell |
46,094
-34,359
| -43% | -$2.45M | 0.07% | 294 |
|
|
2019
Q1 | $6.31M | Buy |
80,453
+76,106
| +1,751% | +$5.97M | 0.15% | 151 |
|
|
2018
Q4 | $368K | Buy |
4,347
+1,458
| +50% | +$123K | 0.01% | 785 |
|
|
2018
Q3 | $495K | Buy |
+2,889
| New | +$495K | 0.01% | 782 |
|
|
2017
Q3 | – | Sell |
-2,919
| Closed | -$221K | – | 796 |
|
|
2017
Q2 | $221K | Buy |
2,919
+337
| +13% | +$25.5K | 0.01% | 775 |
|
|
2017
Q1 | $171K | Buy |
2,582
+993
| +62% | +$65.8K | 0.01% | 780 |
|
|
2016
Q4 | $101K | Buy |
1,589
+305
| +24% | +$19.4K | ﹤0.01% | 748 |
|
|
2016
Q3 | $82K | Buy |
1,284
+160
| +14% | +$10.2K | ﹤0.01% | 730 |
|
|
2016
Q2 | $84K | Buy |
1,124
+164
| +17% | +$12.3K | ﹤0.01% | 717 |
|
|
2016
Q1 | $64K | Hold |
960
| – | – | ﹤0.01% | 713 |
|
|
2015
Q4 | $65K | Buy |
960
+56
| +6% | +$3.79K | ﹤0.01% | 705 |
|
|
2015
Q3 | $48K | Hold |
904
| – | – | ﹤0.01% | 715 |
|
|
2015
Q2 | $57K | Hold |
904
| – | – | ﹤0.01% | 760 |
|
|
2015
Q1 | $43K | Buy |
904
+151
| +20% | +$7.18K | ﹤0.01% | 781 |
|
|
2014
Q4 | $25K | Sell |
753
-45
| -6% | -$1.49K | ﹤0.01% | 785 |
|
|
2014
Q3 | $23K | Buy |
798
+223
| +39% | +$6.43K | ﹤0.01% | 788 |
|
|
2014
Q2 | $22K | Buy |
575
+168
| +41% | +$6.43K | ﹤0.01% | 815 |
|
|
2014
Q1 | $17K | Buy |
407
+30
| +8% | +$1.25K | ﹤0.01% | 778 |
|
|
2013
Q4 | $12K | Buy |
377
+72
| +24% | +$2.29K | ﹤0.01% | 844 |
|
|
2013
Q3 | $8K | Buy |
+305
| New | +$8K | ﹤0.01% | 801 |
|